Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1968 2
1969 7
1970 4
1971 4
1972 2
1973 2
1974 2
1975 2
1976 12
1977 2
1978 6
1979 1
1980 7
1981 8
1982 11
1983 15
1984 6
1985 12
1986 7
1987 3
1988 5
1989 11
1990 5
1991 4
1992 14
1993 4
1994 7
1995 8
1996 7
1997 13
1998 13
1999 11
2000 5
2001 8
2002 15
2003 13
2004 33
2005 22
2006 32
2007 23
2008 26
2009 27
2010 32
2011 41
2012 49
2013 50
2014 44
2015 43
2016 46
2017 39
2018 39
2019 39
2020 73
2021 73
2022 81
2023 74
2024 72
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,090 results

Results by year

Filters applied: . Clear all
Page 1
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma.
Powles T, Assaf ZJ, Davarpanah N, Banchereau R, Szabados BE, Yuen KC, Grivas P, Hussain M, Oudard S, Gschwend JE, Albers P, Castellano D, Nishiyama H, Daneshmand S, Sharma S, Zimmermann BG, Sethi H, Aleshin A, Perdicchio M, Zhang J, Shames DS, Degaonkar V, Shen X, Carter C, Bais C, Bellmunt J, Mariathasan S. Powles T, et al. Among authors: nishiyama h. Nature. 2021 Jul;595(7867):432-437. doi: 10.1038/s41586-021-03642-9. Epub 2021 Jun 16. Nature. 2021. PMID: 34135506 Clinical Trial.
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.
Powles T, Catto JWF, Galsky MD, Al-Ahmadie H, Meeks JJ, Nishiyama H, Vu TQ, Antonuzzo L, Wiechno P, Atduev V, Kann AG, Kim TH, Suárez C, Chang CH, Roghmann F, Özgüroğlu M, Eigl BJ, Oliveira N, Buchler T, Gadot M, Zakharia Y, Armstrong J, Gupta A, Hois S, van der Heijden MS; NIAGARA Investigators. Powles T, et al. Among authors: nishiyama h. N Engl J Med. 2024 Nov 14;391(19):1773-1786. doi: 10.1056/NEJMoa2408154. Epub 2024 Sep 15. N Engl J Med. 2024. PMID: 39282910 Clinical Trial.
Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial.
Bellmunt J, Hussain M, Gschwend JE, Albers P, Oudard S, Castellano D, Daneshmand S, Nishiyama H, Majchrowicz M, Degaonkar V, Shi Y, Mariathasan S, Grivas P, Drakaki A, O'Donnell PH, Rosenberg JE, Geynisman DM, Petrylak DP, Hoffman-Censits J, Bedke J, Kalebasty AR, Zakharia Y, van der Heijden MS, Sternberg CN, Davarpanah NN, Powles T; IMvigor010 Study Group. Bellmunt J, et al. Among authors: nishiyama h. Lancet Oncol. 2021 Apr;22(4):525-537. doi: 10.1016/S1470-2045(21)00004-8. Epub 2021 Mar 12. Lancet Oncol. 2021. PMID: 33721560 Free PMC article. Clinical Trial.
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial.
Necchi A, Roumiguié M, Kamat AM, Shore ND, Boormans JL, Esen AA, Lebret T, Kandori S, Bajorin DF, Krieger LEM, Niglio SA, Uchio EM, Seo HK, de Wit R, Singer EA, Grivas P, Nishiyama H, Li H, Baranwal P, Van den Sigtenhorst-Fijlstra M, Kapadia E, Kulkarni GS. Necchi A, et al. Among authors: nishiyama h. Lancet Oncol. 2024 Jun;25(6):720-730. doi: 10.1016/S1470-2045(24)00178-5. Epub 2024 May 10. Lancet Oncol. 2024. PMID: 38740030 Clinical Trial.
Oral hyaluronan relieves knee pain: a review.
Oe M, Tashiro T, Yoshida H, Nishiyama H, Masuda Y, Maruyama K, Koikeda T, Maruya R, Fukui N. Oe M, et al. Among authors: nishiyama h. Nutr J. 2016 Jan 27;15:11. doi: 10.1186/s12937-016-0128-2. Nutr J. 2016. PMID: 26818459 Free PMC article. Review.
Biomarkers for precision medicine in bladder cancer.
Kojima T, Kawai K, Miyazaki J, Nishiyama H. Kojima T, et al. Among authors: nishiyama h. Int J Clin Oncol. 2017 Apr;22(2):207-213. doi: 10.1007/s10147-016-1068-8. Epub 2016 Nov 29. Int J Clin Oncol. 2017. PMID: 27896485 Review.
Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma: A prospective study.
Tajiri T, Suzuki M, Nishiyama H, Ozawa Y, Kurokawa R, Ito K, Fukumitsu K, Mori Y, Kanemitsu Y, Fukuda S, Uemura T, Ohkubo H, Takemura M, Maeno K, Ito Y, Oguri T, Iwasaki S, Niimi A. Tajiri T, et al. Among authors: nishiyama h. Ann Allergy Asthma Immunol. 2024 Nov;133(5):550-558.e2. doi: 10.1016/j.anai.2024.07.001. Epub 2024 Jul 6. Ann Allergy Asthma Immunol. 2024. PMID: 38972450
Metastatic Cardiac Tumor-Induced Acute Coronary Syndrome.
Uetani T, Inaba S, Nishiyama H, Yamaguchi O. Uetani T, et al. Among authors: nishiyama h. JACC Cardiovasc Interv. 2020 Oct 26;13(20):e179-e180. doi: 10.1016/j.jcin.2020.08.016. Epub 2020 Sep 30. JACC Cardiovasc Interv. 2020. PMID: 33011140 Free article. No abstract available.
1,090 results